Fresh analysis reveals that individuals who come off blockbuster slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Research printed in a major medical journal points out that while obese individuals often shed a large proportion of their body weight while on the medication, the mass comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users using such treatments need to be cognizant of the potential of fast rebound weight gain when the therapy ends," warns expert Dr. Susan Jebb.
That rate of regain suggests a return to original mass in about a year and a half.
Weighing Approaches
The study, which reviewed 37 of trials involving over 9,000 of participants, contrasted the results of these new drugs with other pills.
Scientists emphasize that individuals who shed pounds through diet and exercise usually have a slower weight regain—around 100 grams monthly—after stopping.
Understanding the Quick Rebound
Experts believe the mechanism of the injections is key to understanding the accelerated weight return.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing GLP-1 levels several times higher than normal might result in the system to produce less of its endogenous hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' means appetite is unsuppressed, making excessive eating far more likely."
A Chronic Disease?
Medical guidelines recommend the injections for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals say that, considering the significant potential of relapse, the treatment should be considered ongoing.
This perspective is reinforced by drug manufacturers, who say that the findings "underscore the chronic nature of excess weight," comparing it to managing diseases like high blood pressure.
User Testimonies
Individuals who have discontinued the medication report a sudden return of hunger.
"I experienced a trigger activating and I was suddenly starving," described one woman.
This challenge is worsened if users have not developed sustainable lifestyle or habit changes during treatment.
Growing Interest
Survey data show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is more common among women compared to men.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the medications through private healthcare rather than public health services.
Ultimately, experts emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on ongoing lifestyle changes.
